iPonatic-Portable Molecule Workstation
iPonatic-Portable Molecule Workstation

iPonatic-Portable Molecule Workstation

BRIEF

Innovations in molecular assays—especially on the point-of-care testing (POCT) front—have spread this testing from molecular diagnostics laboratories into clinical microbiology laboratories—and now into general laboratories and even clinics and exam rooms. [1]

Access to sensitive and rapid infectious disease diagnostic assays is essential for accurate diagnosis, effective treatment, and timely infection control, making POCT vital to reducing TAT.  With novel POCT on the horizon, future studies are warranted to determine cost savings, antimicrobial usage, TAT, patient impact, and how to best implement in non-microbiology clinical laboratories and clinics. [2]

Sansure iPonatic (Portable Molecule Workstation) aims to subvert  traditional diagnostic mode and bring precision healthcare into thousands of households. It can provide quickly and convenient diagnosis experience for clinical emergency, health management, military safety, biological emergency and other applications.

CORE TECHNOLOGIES

  • Rapid nucleic acid lysis at room temperature within 1 minute
  • Ultra fast amplification system in 8-45 minutes
  • Integrated automatic data analysis software
  • Results immediately printed by built-in printer

PERFORMANCE

 

Diagnostic results consistent with international mainstream PCR instruments

PARAMETERS

Model S-Q31A S-Q31B
Detection platform Real-time PCR
Detection module 1 amplification module 4 amplification modules
Temperature control Liquid metal coated ceramic heating / Air cooling technology
Heating rate ≥6.0℃ /s (from 50℃ to 95℃ )
Cooling rate ≥2.0℃ /s (from 95℃ to 50℃ )
Excitation light source LED
Detector High sensitivity photodiode
Applicable dyes FAM VIC ROX CY5
Sensitivity Can detect single copy gene
Electrical specification AC 100-200V 50/60Hz
Dimension 230×284×376 mm (L×W×H) 336.5 × 280 × 435 mm (L×W×H)
Weight 9.7Kg 13Kg

TEST MENU

Respiratory Infections : SARS-CoV-2, SARS-CoV-2/FluA/B, MP, ADV, BP….
HPV Infections : HrHPV, HPV 13+2, HPV 16/18, HPV 6/11….
Children’s health : EBV, HCMV….
STIs : CT/UU/NG, CT, UU, NG, HSV-2….

Other test projects are under development

 

References
[1].  Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: Past, present, and future. J Clin Microbiol 2017;55:2313-20.
[2]. Paige M.K. Larkin,   Omai B. Garner. Molecular Point-of-Care Testing in Clinical Laboratories Laboratorians can lead a new era in rapid testing with expertise in quality control and result interpretation. Clinical Laboratory News. JUL.1.2020
0000